Tapewire

Nasdaq · USD

MBRX

Moleculin Biotech, Inc.

Export transactions ↓
Tapewire entity
7886
SEC CIK
0001659617
Parsed reports
128

Last 12 months

Inside the activity.

3 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202630
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 07, 2021 Filed Jun 9, 2021 16:25 UTC GrantStock option (right to buy) · Derivative 10,000 Not disclosed Strike: $3.95 Not disclosed
Disclosure

SEC source: 0001437749-21-014426 · rdgdoc.xml · derivative · entry 1

George Robert E. · CIK 0001674701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,668

Underlying: Common Stock · 10,000 shares

Expires 2031-06-07

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 20:26 UTC GrantStock option (right to buy) · Derivative 10,000 Not disclosed Strike: $3.95 Not disclosed
Disclosure

SEC source: 0001437749-21-014429 · rdgdoc.xml · derivative · entry 1

CANNON MICHAEL D · CIK 0001203602 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,668

Underlying: Common Stock · 10,000 shares

Expires 2031-06-07

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 20:26 UTC GrantStock option (right to buy) · Derivative 10,000 Not disclosed Strike: $3.95 Not disclosed
Disclosure

SEC source: 0001437749-21-014428 · rdgdoc.xml · derivative · entry 1

Cermak Elizabeth · CIK 0001471971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 10,000 shares

Expires 2031-06-07

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 20:25 UTC GrantStock option (right to buy) · Derivative 10,000 Not disclosed Strike: $3.95 Not disclosed
Disclosure

SEC source: 0001437749-21-014427 · rdgdoc.xml · derivative · entry 1

Climaco John M · CIK 0001546797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,168

Underlying: Common Stock · 10,000 shares

Expires 2031-06-07

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
October 02, 2020 Filed Oct 5, 2020 21:26 UTC GrantStock option (right to buy) · Derivative 40,000 Not disclosed Strike: $0.81 Not disclosed
Disclosure

SEC source: 0001437749-20-020742 · rdgdoc.xml · derivative · entry 1

Cermak Elizabeth · CIK 0001471971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-10-02

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
August 20, 2020 Filed Aug 24, 2020 20:04 UTC GrantStock option (right to buy) · Derivative 100,000 Not disclosed Strike: $0.96 Not disclosed
Disclosure

SEC source: 0001659617-20-000206 · wf-form4_159829941790393.xml · derivative · entry 1

Priebe Waldemar · CIK 0001678516 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-08-20

F2 · price: Issued in connection with the reporting person providing services to the Company.

F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
July 13, 2020 Filed Jul 14, 2020 22:03 UTC
KLEMP WALTER VDirector · CEO and President
Exercise / conversionRestricted Stock Units · Derivative 79,227 $0.00 $0.00
Disclosure

SEC source: 0001659617-20-000178 · wf-form4_159476421761509.xml · derivative · entry 3

KLEMP WALTER V · CIK 0000938419 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,430,891

Underlying: Common Stock · 79,227 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On July 11, 2019, the reporting person was granted 316,907 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: On July 11, 2019, the reporting person was granted 316,907 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
July 13, 2020 Filed Jul 14, 2020 22:03 UTC
KLEMP WALTER VDirector · CEO and President
Tax withholdingCommon Stock 19,292 $0.86 $16,513.95
Disclosure

SEC source: 0001659617-20-000178 · wf-form4_159476421761509.xml · nonDerivative · entry 2

KLEMP WALTER V · CIK 0000938419 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,027,659

F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards.

Read SEC document
July 13, 2020 Filed Jul 14, 2020 22:03 UTC
KLEMP WALTER VDirector · CEO and President
Exercise / conversionCommon Stock 79,227 Not disclosed Not disclosed
Disclosure

SEC source: 0001659617-20-000178 · wf-form4_159476421761509.xml · nonDerivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,046,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 21:24 UTC
KLEMP WALTER VDirector · CEO and President
GrantRestricted Stock Units · Derivative 353,211 Not disclosed Not disclosed
Disclosure

SEC source: 0001659617-20-000173 · wf-form4_159415661342622.xml · derivative · entry 2

KLEMP WALTER V · CIK 0000938419 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,510,118

Underlying: Common Stock · 353,211 shares

Expires not disclosed

F3 · derivative.exercise_price: (3) Each restricted stock unit represents a contingent right to receive one share of Company common stock.

F2 · price: (2) Issued in connection with the reporting person's employment with the Company.

F4 · derivative.exercise_date: (4) The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

F4 · derivative.expiration_date: (4) The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 21:24 UTC
KLEMP WALTER VDirector · CEO and President
GrantStock option (right to buy) · Derivative 500,000 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001659617-20-000173 · wf-form4_159415661342622.xml · derivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,156,907

Underlying: Common Stock · 500,000 shares

Expires 2030-07-02

F2 · price: (2) Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 21:14 UTC
Foster Jonathan P.Exec. Vice President and CFO
GrantStock option (right to buy) · Derivative 460,000 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001659617-20-000172 · wf-form4_159415646381168.xml · derivative · entry 1

Foster Jonathan P. · CIK 0001545414 · Exec. Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,621,000

Underlying: Common Stock · 460,000 shares

Expires 2030-07-02

F2 · price: (2) Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 21:13 UTC
PICKER DONALD HChief Science Officer
GrantStock option (right to buy) · Derivative 100,000 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001659617-20-000171 · wf-form4_159415638537678.xml · derivative · entry 1

PICKER DONALD H · CIK 0001266800 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,000

Underlying: Common Stock · 100,000 shares

Expires 2030-07-02

F2 · price: (2) Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 16:30 UTC GrantStock option (right to buy) · Derivative 15,000 Not disclosed Strike: $1.12 Not disclosed
Disclosure

SEC source: 0001659617-20-000151 · wf-form4_159242581160556.xml · derivative · entry 1

George Robert E. · CIK 0001674701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 15,000 shares

Expires 2030-06-16

F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors in each vesting date.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 20:34 UTC GrantStock option (right to buy) · Derivative 15,000 Not disclosed Strike: $1.12 Not disclosed
Disclosure

SEC source: 0001659617-20-000153 · wf-form4_159242604415421.xml · derivative · entry 1

CANNON MICHAEL D · CIK 0001203602 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 15,000 shares

Expires 2030-06-15

F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors in each vesting date.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 20:32 UTC GrantStock option (right to buy) · Derivative 15,000 Not disclosed Strike: $1.12 Not disclosed
Disclosure

SEC source: 0001659617-20-000152 · wf-form4_159242592252592.xml · derivative · entry 1

Climaco John M · CIK 0001546797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 15,000 shares

Expires 2030-06-15

F2 · price: (2) Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors in each vesting date.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:21 UTC
KLEMP WALTER VDirector · CEO and President
GrantRestricted Stock Units · Derivative 316,907 Not disclosed Not disclosed
Disclosure

SEC source: 0001659617-19-000105 · wf-form4_156322208980596.xml · derivative · entry 2

KLEMP WALTER V · CIK 0000938419 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,656,907

Underlying: Common Stock · 316,907 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Company common stock.

F2 · price: Issued in connection with the reporting person's employment with the Company.

F4 · derivative.exercise_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

F4 · derivative.expiration_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:21 UTC
KLEMP WALTER VDirector · CEO and President
GrantStock option (right to buy) · Derivative 500,000 Not disclosed Strike: $1.31 Not disclosed
Disclosure

SEC source: 0001659617-19-000105 · wf-form4_156322208980596.xml · derivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,340,000

Underlying: Common Stock · 500,000 shares

Expires 2029-07-11

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 16:17 UTC GrantStock option (right to buy) · Derivative 35,000 Not disclosed Strike: $1.31 Not disclosed
Disclosure

SEC source: 0001659617-19-000104 · wf-form4_156322181376648.xml · derivative · entry 1

George Robert E. · CIK 0001674701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 35,000 shares

Expires 2029-07-11

F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:25 UTC GrantStock option (right to buy) · Derivative 35,000 Not disclosed Strike: $1.31 Not disclosed
Disclosure

SEC source: 0001659617-19-000107 · wf-form4_156322231160782.xml · derivative · entry 1

CANNON MICHAEL D · CIK 0001203602 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 35,000 shares

Expires 2029-07-11

F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:14 UTC GrantStock option (right to buy) · Derivative 35,000 Not disclosed Strike: $1.31 Not disclosed
Disclosure

SEC source: 0001659617-19-000103 · wf-form4_156322163353261.xml · derivative · entry 1

Climaco John M · CIK 0001546797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 35,000 shares

Expires 2029-07-11

F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:06 UTC
PICKER DONALD HChief Science Officer
GrantStock option (right to buy) · Derivative 100,000 Not disclosed Strike: $1.31 Not disclosed
Disclosure

SEC source: 0001659617-19-000102 · wf-form4_156322120093753.xml · derivative · entry 1

PICKER DONALD H · CIK 0001266800 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,000

Underlying: Common Stock · 100,000 shares

Expires 2029-07-11

F2 · price: (2) Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:04 UTC
Foster Jonathan P.Exec. Vice President and CFO
GrantStock option (right to buy) · Derivative 315,000 Not disclosed Strike: $1.31 Not disclosed
Disclosure

SEC source: 0001659617-19-000101 · wf-form4_156322106686428.xml · derivative · entry 1

Foster Jonathan P. · CIK 0001545414 · Exec. Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,161,000

Underlying: Common Stock · 315,000 shares

Expires 2029-07-11

F2 · price: (2) Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
May 22, 2019 Filed May 24, 2019 17:00 UTC GrantStock option (right to buy) · Derivative 15,000 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0001144204-19-028195 · tv522431_4.xml · derivative · entry 1

George Robert E. · CIK 0001674701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 15,000 shares

Expires 2029-05-22

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
May 22, 2019 Filed May 24, 2019 21:00 UTC GrantStock option (right to buy) · Derivative 15,000 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0001144204-19-028197 · tv522433_4.xml · derivative · entry 1

Climaco John M · CIK 0001546797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 15,000 shares

Expires 2029-05-22

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
May 22, 2019 Filed May 24, 2019 21:00 UTC GrantStock option (right to buy) · Derivative 15,000 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0001144204-19-028196 · tv522432_4.xml · derivative · entry 1

CANNON MICHAEL D · CIK 0001203602 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 15,000 shares

Expires 2029-05-22

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
June 06, 2018 Filed Jun 8, 2018 21:24 UTC
KLEMP WALTER VDirector · CEO and President
GrantStock option (right to buy) · Derivative 603,000 Not disclosed Strike: $1.82 Not disclosed
Disclosure

SEC source: 0001144204-18-033605 · tv496089_4.xml · derivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 943,000

Underlying: Common stock · 603,000 shares

Expires 2028-06-06

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
June 06, 2018 Filed Jun 8, 2018 17:25 UTC GrantStock option (right to buy) · Derivative 35,000 Not disclosed Strike: $1.82 Not disclosed
Disclosure

SEC source: 0001144204-18-033607 · tv496091_4.xml · derivative · entry 1

George Robert E. · CIK 0001674701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 35,000 shares

Expires 2028-06-06

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
June 06, 2018 Filed Jun 8, 2018 21:27 UTC GrantStock option (right to buy) · Derivative 35,000 Not disclosed Strike: $1.82 Not disclosed
Disclosure

SEC source: 0001144204-18-033609 · tv496093_4.xml · derivative · entry 1

Climaco John M · CIK 0001546797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 35,000 shares

Expires 2028-06-06

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Companya(euro)(TM)s Board of Directors on each vesting date.

Read SEC document
June 06, 2018 Filed Jun 8, 2018 21:27 UTC GrantStock option (right to buy) · Derivative 35,000 Not disclosed Strike: $1.82 Not disclosed
Disclosure

SEC source: 0001144204-18-033610 · tv496094_4.xml · derivative · entry 1

CANNON MICHAEL D · CIK 0001203602 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 35,000 shares

Expires 2028-06-06

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
June 06, 2018 Filed Jun 8, 2018 21:25 UTC
PICKER DONALD HChief Science Officer
GrantStock option (right to buy) · Derivative 75,000 Not disclosed Strike: $1.82 Not disclosed
Disclosure

SEC source: 0001144204-18-033608 · tv496092_4.xml · derivative · entry 1

PICKER DONALD H · CIK 0001266800 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,000

Underlying: Common stock · 75,000 shares

Expires 2028-06-06

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
June 06, 2018 Filed Jun 8, 2018 21:24 UTC
Foster Jonathan P.Chief Financial Officer
GrantStock option (right to buy) · Derivative 301,000 Not disclosed Strike: $1.82 Not disclosed
Disclosure

SEC source: 0001144204-18-033606 · tv496090_4.xml · derivative · entry 1

Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 846,000

Underlying: Common stock · 301,000 shares

Expires 2028-06-06

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
June 06, 2018 Filed Jul 15, 2019 20:22 UTC Amendment
KLEMP WALTER VDirector · CEO and President
GrantStock option (right to buy) · Derivative 500,000 Not disclosed Strike: $1.82 Not disclosed
Disclosure

SEC source: 0001659617-19-000106 · wf-form4a_156322215943382.xml · derivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 840,000

Underlying: Common Stock · 500,000 shares

Expires 2028-06-06

F1 · shares: As previously reported on a Form 4 filed on June 8, 2018 by the reporting person, the reporting person reported acquiring stock options to purchase 603,000 shares of common stock. However, the Company subsequently determined that stock options to purchase 103,000 shares of common stock under the Company's 2015 Stock Plan were not validly granted pursuant to the plan because they exceeded the limit on the number of stock options that may be granted to any individual participant one year period. Accordingly, the attempted grant of these excess stock options was ineffective, and they were never granted to the reporting person. The reporting person is filing this amendment to report the correct amount of stock options acquired, and to revise the vesting schedule for the stock options to provide that 150,750 options vested as of June 6, 2019, and the remaining options shall vest in three equal installments on June 6, 2020, 2021, and 2022.

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: As previously reported on a Form 4 filed on June 8, 2018 by the reporting person, the reporting person reported acquiring stock options to purchase 603,000 shares of common stock. However, the Company subsequently determined that stock options to purchase 103,000 shares of common stock under the Company's 2015 Stock Plan were not validly granted pursuant to the plan because they exceeded the limit on the number of stock options that may be granted to any individual participant one year period. Accordingly, the attempted grant of these excess stock options was ineffective, and they were never granted to the reporting person. The reporting person is filing this amendment to report the correct amount of stock options acquired, and to revise the vesting schedule for the stock options to provide that 150,750 options vested as of June 6, 2019, and the remaining options shall vest in three equal installments on June 6, 2020, 2021, and 2022.

Read SEC document
October 03, 2017 Filed Oct 5, 2017 21:59 UTC
KLEMP WALTER VDirector · CEO · 10% owner
GrantStock option (right to buy) · Derivative 340,000 Not disclosed Strike: $2.49 Not disclosed
Disclosure

SEC source: 0001144204-17-051543 · v476495_4.xml · derivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director · CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,000

Underlying: Common stock · 340,000 shares

Expires 2027-10-03

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
October 03, 2017 Filed Oct 5, 2017 22:04 UTC
PICKER DONALD HChief Science Officer
GrantStock option (right to buy) · Derivative 60,000 Not disclosed Strike: $2.49 Not disclosed
Disclosure

SEC source: 0001144204-17-051549 · v476494_4.xml · derivative · entry 1

PICKER DONALD H · CIK 0001266800 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common stock · 60,000 shares

Expires 2027-10-03

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
October 03, 2017 Filed Oct 5, 2017 22:02 UTC
Foster Jonathan P.Chief Financial Officer
GrantStock option (right to buy) · Derivative 145,000 Not disclosed Strike: $2.49 Not disclosed
Disclosure

SEC source: 0001144204-17-051545 · v476493_4.xml · derivative · entry 1

Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 545,000

Underlying: Common stock · 145,000 shares

Expires 2027-10-03

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
August 16, 2017 Filed Aug 18, 2017 22:01 UTC
KLEMP WALTER VDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 100,000 $1.70 $170,300.00
Disclosure

SEC source: 0001144204-17-044233 · v473535_4.xml · nonDerivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 967,724

F1 · kind: The reporting person entered into a private sale agreement for the shares of common stock set forth in the table. The 12,000 shares of common stock purchased by the reporting person on May 11, 2017 are a matching transaction under Section 16 of the Securities Exchange Act of 1934 with 12,000 shares of common stock sold by the reporting person as set forth in the table above. In Accordance with Section 16, the reporting person will disgorge to the issuer an aggregate short-swing profit of $10,716.

F2 · balance_after: In addition to the shares held directly by the reporting person, the reporting person is the majority shareholder and control person of Annamed, Inc. Annamed, Inc. holds 1,425,000 shares of Issuer common stock. The Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Annamed, Inc.

Read SEC document
August 16, 2017 Filed Aug 18, 2017 22:00 UTC SaleCommon Stock 100,000 $1.70 $170,300.00
Disclosure

SEC source: 0001144204-17-044232 · v473534_4.xml · nonDerivative · entry 1

Priebe Waldemar · CIK 0001678516 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,781,573

F1 · kind: The reporting person entered into a private sale agreement for the shares of common stock set forth in the table.

F2 · balance_after: In addition to the shares held directly by the reporting person, The reporting person is a shareholder and control person of IntertechBio Corp. IntertechBio Corp. holds 630,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by IntertechBio Corp. The reporting person is also a shareholder and control person of Houston Pharmaceuticals, Inc. Houston Pharmaceuticals, Inc. holds 629,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Houston Pharmaceuticals, Inc.

Read SEC document
July 24, 2017 Filed Jul 26, 2017 21:08 UTC GrantOption to purchase common stock · Derivative 15,000 Not disclosed Strike: $1.87 Not disclosed
Disclosure

SEC source: 0001144204-17-038497 · v471464_4.xml · derivative · entry 1

George Robert E. · CIK 0001674701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 15,000 shares

Expires 2027-07-24

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
July 24, 2017 Filed Jul 27, 2017 01:06 UTC GrantOption to purchase common stock · Derivative 20,000 Not disclosed Strike: $1.87 Not disclosed
Disclosure

SEC source: 0001144204-17-038495 · v471461_4.xml · derivative · entry 1

Climaco John M · CIK 0001546797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-07-24

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
July 24, 2017 Filed Jul 27, 2017 01:10 UTC GrantOption to purchase common stock · Derivative 15,000 Not disclosed Strike: $1.87 Not disclosed
Disclosure

SEC source: 0001144204-17-038499 · v471463_4.xml · derivative · entry 1

CANNON MICHAEL D · CIK 0001203602 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 15,000 shares

Expires 2027-07-24

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
May 11, 2017 Filed May 12, 2017 21:19 UTC
KLEMP WALTER VDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 12,000 $0.81 $9,720.00
Disclosure

SEC source: 0001144204-17-026954 · v466826_form4.xml · nonDerivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,067,724

F1 · balance_after: In addition to the shares held directly by the reporting person, the reporting person is the majority shareholder and control person of Annamed, Inc. Annamed, Inc. holds 1,425,000 shares of Issuer common stock. The Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Annamed, Inc.

Read SEC document
May 05, 2017 Filed May 5, 2017 16:30 UTC PurchaseCommon Stock 1,000 $0.82 $820.00
Disclosure

SEC source: 0001144204-17-024864 · v466235_4.xml · nonDerivative · entry 1

Northcut Jacqueline · CIK 0001674644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Read SEC document
April 28, 2017 Filed Apr 28, 2017 16:31 UTC PurchaseCommon Stock 1,000 $0.94 $938.40
Disclosure

SEC source: 0001144204-17-023240 · v465565_4.xml · nonDerivative · entry 1

George Robert E. · CIK 0001674701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Read SEC document
April 25, 2017 Filed Apr 26, 2017 20:30 UTC
Foster Jonathan P.Exec. Vice President & CFO
PurchaseCommon Stock 10,000 $0.86 $8,649.00
Disclosure

SEC source: 0001144204-17-022289 · v465197_form4.xml · nonDerivative · entry 1

Foster Jonathan P. · CIK 0001545414 · Exec. Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
September 23, 2016 Filed Sep 27, 2016 20:58 UTC GrantOption to purchase common stock · Derivative 20,000 Not disclosed Strike: $5.71 Not disclosed
Disclosure

SEC source: 0001144204-16-125634 · v449473_4.xml · derivative · entry 1

Northcut Jacqueline · CIK 0001674644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-09-23

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
September 23, 2016 Filed Sep 27, 2016 20:58 UTC GrantOption to purchase common stock · Derivative 20,000 Not disclosed Strike: $5.71 Not disclosed
Disclosure

SEC source: 0001144204-16-125633 · v449472_4.xml · derivative · entry 1

George Robert E. · CIK 0001674701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-09-23

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document
September 23, 2016 Filed Sep 28, 2016 00:58 UTC GrantOption to purchase common stock · Derivative 20,000 Not disclosed Strike: $5.71 Not disclosed
Disclosure

SEC source: 0001144204-16-125635 · v449474_4.xml · derivative · entry 1

CANNON MICHAEL D · CIK 0001203602 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-09-23

F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.